Home
>
National Drug Code (NDC)
>
Mercaptopurine
Mercaptopurine - 0093-5510-06 - (Mercaptopurine)
Drug Information of Mercaptopurine
| Product NDC: | 0093-5510 |
| Proprietary Name: | Mercaptopurine |
| Non Proprietary Name: | Mercaptopurine |
| Active Ingredient(s): | 50 mg/1 & nbsp; Mercaptopurine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mercaptopurine
| Product NDC: | 0093-5510 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009053 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050427 |
Package Information of Mercaptopurine
| Package NDC: | 0093-5510-06 |
| Package Description: | 60 TABLET in 1 BOTTLE (0093-5510-06) |
NDC Information of Mercaptopurine
| NDC Code | 0093-5510-06 |
| Proprietary Name | Mercaptopurine |
| Package Description | 60 TABLET in 1 BOTTLE (0093-5510-06) |
| Product NDC | 0093-5510 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mercaptopurine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20050427 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | MERCAPTOPURINE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
